Search by Drug Name or NDC
NDC 00005-0100-10 Trumenba 60; 60 ug/.5mL; ug/.5mL Details
Trumenba 60; 60 ug/.5mL; ug/.5mL
Trumenba is a INTRAMUSCULAR INJECTION, SUSPENSION in the VACCINE category. It is labeled and distributed by Wyeth Pharmaceutical Division of Wyeth Holdings LLC. The primary component is NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN; NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN.
MedlinePlus Drug Summary
Why get vaccinated? Meningococcal B vaccine can help protect against meningococcal disease caused by serogroup B. A different meningococcal vaccine is available that can help protect against serogroups A, C, W, and Y. Meningococcal disease can cause meningitis (infection of the lining of the brain and spinal cord) and infections of the blood. Even when it is treated, meningococcal disease kills 10 to 15 infected people out of 100. And of those who survive, about 10 to 20 out of every 100 will suffer disabilities such as hearing loss, brain damage, kidney damage, loss of limbs, nervous system problems, or severe scars from skin grafts. Meningococcal disease is rare and has declined in the United States since the 1990s. However, it is a severe disease with a significant risk of death or lasting disabilities in people who get it. Anyone can get meningococcal disease. Certain people are at increased risk, including: Infants younger than one year old Adolescents and young adults 16 through 23 years old People with certain medical conditions that affect the immune system Microbiologists who routinely work with isolates of N. meningitidis, the bacteria that cause meningococcal disease People at risk because of an outbreak in their community
Related Packages: 00005-0100-10Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Serogroup B Meningococcal Vaccine (MenB)
Product Information
NDC | 00005-0100 |
---|---|
Product ID | 0005-0100_9eb46fff-908d-433d-bf28-bc896f6a0833 |
Associated GPIs | 1720004012E610 |
GCN Sequence Number | 073089 |
GCN Sequence Number Description | N.meningitidis B,lipid fHBP rc SYRINGE 120MCG/0.5 INTRAMUSC |
HIC3 | W7Q |
HIC3 Description | GRAM NEGATIVE COCCI VACCINES |
GCN | 37413 |
HICL Sequence Number | 041557 |
HICL Sequence Number Description | NEISSERIA MENINGITIDIS GROUP B, LIPIDATED FHBP RECOMBINANT |
Brand/Generic | Brand |
Proprietary Name | Trumenba |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | meningococcal group B vaccine |
Product Type | VACCINE |
Dosage Form | INJECTION, SUSPENSION |
Route | INTRAMUSCULAR |
Active Ingredient Strength | 60; 60 |
Active Ingredient Units | ug/.5mL; ug/.5mL |
Substance Name | NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN; NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN |
Labeler Name | Wyeth Pharmaceutical Division of Wyeth Holdings LLC |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA125549 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00005-0100-10 (00005010010)
NDC Package Code | 0005-0100-10 |
---|---|
Billing NDC | 00005010010 |
Package | 10 SYRINGE in 1 CARTON (0005-0100-10) / .5 mL in 1 SYRINGE (0005-0100-01) |
Marketing Start Date | 2014-11-05 |
NDC Exclude Flag | N |
Pricing Information | N/A |